Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas

PurposeTo compare the efficacy of TACE combined with sorafenib and TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) combined with arterioportal fistulas (APFs), and discuss the efficacy and safety of TACE combined wit...

Full description

Bibliographic Details
Main Authors: Xiao-Hui Zhao, Hang Yuan, Wei-Li Xia, Li-Lin Zhang, Zhen Li, Guang-Shao Cao, Hai-Liang Li, Wei-Jun Fan, Hong-Le Li, Chen-Yang Guo, Quan-Jun Yao, Wen-Bo Zhu, Hong-Tao Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
arterioportal fistulas
portal vein tumor thrombus
125 I seed
transarterial chemoembolization
sorafenib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.977462/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.977462/full

Similar Items